nach oben

CardioVascular and Interventional Radiology

Erschienen in:

16.07.2020 | Technical Note

Balloon-Occluded MWA (b-MWA) Followed by Balloon-Occluded TACE (b-TACE): Technical Note on a New Combined Single-Step Therapy for Single Large HCC

verfasst von: Roberto Iezzi, Alessandro Posa, Alessandro Tanzilli, Francesca Carchesio, Maurizio Pompili, Riccardo Manfredi

Erschienen in: CardioVascular and Interventional Radiology | Ausgabe 11/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose To evaluate the feasibility, safety and efficacy of a combined single-step therapy in patients with unresectable single large (> 5 cm) hepatocellular carcinoma (HCC), with balloon-occluded microwave ablation (b-MWA) plus transcatheter arterial balloon-occluded chemoembolization (b-TACE).

Materials & Methods

Five consecutive Child A patients (mean age: 71.4 ± 3.2 yo; range 68–76 yo) with an unresectable single large HCC (> 5 cm) (mean size: 5.7 ± 0.6 cm; range 5.1–6.5 cm) were enrolled in our pilot study. The schedule consisted of percutaneous microwave ablation of the lesion during balloon occlusion of the hepatic artery supplying the tumor (b-MWA), followed by TACE under the occlusion of feeding arteries by a microballoon catheter (b-TACE). Adverse events and intra- and peri-procedural complications were clinically assessed. Early local efficacy was evaluated on 1- and 6-month follow-up multiphasic computed tomography (CT) on the basis of m-RECIST criteria.

Results

Technical success was obtained in all procedures. No major complications occurred. A mean necrotic area of 6.8 ± 0.47 cm (range 6.3–7.4 cm) was obtained, with a complete response at 1-month follow-up obtained in 4 out of 5 lesions, with 1 partial response (less than 30% of residual tumor), successfully treated with a single TACE treatment. No residual tumor or local recurrence was registered at 6-month CT follow-up.

Conclusions

Our preliminary experience seems to demonstrate that b-MWA plus b-TACE could be a safe and effective combined therapy for unresectable large HCC lesions, allowing a high rate of local response also in lesion exceeding 5 cm in size.

Peng ZW, Zhang YJ, Chen MS, Xu L, Liang HH, Lin XJ, Guo RP, Zhang YQ, Lau WY. Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial. J Clin Oncol. 2013;31(4):426–32. https://doi.org/10.1200/JCO.2012.42.9936.CrossRefPubMed

Peng ZW, Zhang YJ, Liang HH, Lin XJ, Guo RP, Chen MS. Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone: a prospective randomized trial. Radiology. 2012;262(2):689–700. https://doi.org/10.1148/radiol.11110637.CrossRefPubMed

Yin X, Zhang L, Wang YH, Zhang BH, Gan YH, Ge NL, Chen Y, Li LX, Ren ZG. Transcatheter arterial chemoembolization combined with radiofrequency ablation delays tumor progression and prolongs overall survival in patients with intermediate (BCLC B) hepatocellular carcinoma. BMC Cancer. 2014;14:849. https://doi.org/10.1186/1471-2407-14-849.CrossRefPubMedPubMedCentral

Ni JY, Liu SS, Xu LF, Sun HL, Chen YT. Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinoma. World J Gastroenterol. 2013;19(24):3872–82. https://doi.org/10.3748/wjg.v19.i24.3872.CrossRefPubMedPubMedCentral

Huo YR, Eslick GD. Microwave ablation compared to radiofrequency ablation for hepatic lesions: a meta-analysis. J Vasc Interv Radiol. 2015;26(8):1139–11146. https://doi.org/10.1016/j.jvir.2015.04.004.CrossRefPubMed

Ginsburg M, Zivin SP, Wroblewski K, Doshi T, Vasnani RJ, Van Ha TG. Comparison of combination therapies in the management of hepatocellular carcinoma: transarterial chemoembolization with radiofrequency ablation versus microwave ablation. J Vasc Interv Radiol. 2015;26(3):330–41. https://doi.org/10.1016/j.jvir.2014.10.047.CrossRefPubMed

Inchingolo R, Posa A, Mariappan M, Spiliopoulos S. Locoregional treatments for hepatocellular carcinoma: current evidence and future directions. World J Gastroenterol. 2019;25(32):4614–28. https://doi.org/10.3748/wjg.v25.i32.4614.CrossRefPubMedPubMedCentral

Saviano A, Iezzi R, Giuliante F, Salvatore L, Mele C, Posa A, Ardito F, De Gaetano AM, HepatoCATT Study Group. Pompili M Liver resection versus radiofrequency ablation plus transcatheter arterial chemoembolization in cirrhotic patients with solitary large hepatocellular carcinoma. J Vasc Interv Radiol. 2017;28(11):1512–9. https://doi.org/10.1016/j.jvir.2017.06.016.CrossRefPubMed

Kim JW, Shin SS, Kim JK, Choi SK, Heo SH, Lim HS, Hur YH, Cho CK, Jeong YY, Kang HK. Radiofrequency ablation combined with transcatheter arterial chemoembolization for the treatment of single hepatocellular carcinoma of 2 to 5 cm in diameter: comparison with surgical resection. Korean J Radiol. 2013;14(4):626–35. https://doi.org/10.3348/kjr.2013.14.4.626.CrossRefPubMedPubMedCentral

10.

Iezzi R, Pompili M, Posa A, Coppola G, Gasbarrini A, Bonomo L. Combined locoregional treatment of patients with hepatocellular carcinoma: state of the art. World J Gastroenterol. 2016;22(6):1935–42. https://doi.org/10.3748/wjg.v22.i6.1935.CrossRefPubMedPubMedCentral

11.

Hatanaka T, Arai H, Kakizaki S. Balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma. World J Hepatol. 2018;10(7):485–95. https://doi.org/10.4254/wjh.v10.i7.485.CrossRefPubMedPubMedCentral

12.

Lucatelli P, Ginnani Corradini L, De Rubeis G, Rocco B, Basilico F, Cannavale A, Nardis PG, Corona M, Saba L, Catalano C, Bezzi M. Balloon-occluded transcatheter arterial chemoembolization (b-TACE) for hepatocellular carcinoma performed with polyethylene-glycol epirubicin-loaded drug-eluting embolics: safety and preliminary results. Cardiovasc Intervent Radiol. 2019;42(6):853–62. https://doi.org/10.1007/s00270-019-02192-y.CrossRefPubMedPubMedCentral

13.

Kim TK, Kim SY, Tang A, Lee JM. Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update. Clin Mol Hepatol. 2019;25(3):245–63. https://doi.org/10.3350/cmh.2018.0090.CrossRefPubMedPubMedCentral

14.

Iezzi R, Pompili M, Annicchiarico EB, Garcovich M, Siciliano M, Gasbarrini A, Manfredi R. ‘Hug sign’: a new radiological sign of intraprocedural success after combined treatment for hepatocellular carcinoma. Hepat Oncol. 2017;4(3):69–73. https://doi.org/10.2217/hep-2017-0017.CrossRefPubMedPubMedCentral

15.

Filippiadis DK, Binkert C, Pellerin O, Hoffmann RT, Krajina A, Pereira PL. Cirse quality assurance document and standards for classification of complications: the cirse classification system. Cardiovasc Intervent Radiol. 2017;40(8):1141–6. https://doi.org/10.1007/s00270-017-1703-4.CrossRefPubMed

16.

Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis. 2010;30(1):52–60. https://doi.org/10.1055/s-0030-1247132.CrossRefPubMed

17.

Lu Z, Wen F, Guo Q, Liang H, Mao X, Sun H. Radiofrequency ablation plus chemoembolization versus radiofrequency ablation alone for hepatocellular carcinoma: a meta-analysis of randomized-controlled trials. Eur J Gastroenterol Hepatol. 2013;25(2):187–94. https://doi.org/10.1097/MEG.0b013e32835a0a07.CrossRefPubMed

18.

Vogl TJ, Nour-Eldin NA, Hammerstingl RM, Panahi B, Naguib NNN. Microwave ablation (MWA): basics, technique and results in primary and metastatic liver neoplasms—review article. Rofo. 2017;189(11):1055–66. https://doi.org/10.1055/s-0043-117410.CrossRefPubMed

19.

Liu C, Liang P, Liu F, Wang Y, Li X, Han Z, Liu C. MWA combined with TACE as a combined therapy for unresectable large-sized hepatocellular carcinoma. Int J Hyperthermia. 2011;27(7):654–62. https://doi.org/10.3109/02656736.2011.605099.CrossRefPubMed

20.

Patidar Y, Garg L, Mukund A, Sarin SK. Early experience of combination therapy of transarterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma measuring 3–7 cm. Indian J Radiol Imaging. 2019;29(1):47–52. https://doi.org/10.4103/ijri.IJRI_352_18.CrossRefPubMedPubMedCentral

21.

Iezzi R, Pompili M, La Torre MF, Campanale MC, Montagna M, Saviano A, Cesario V, Siciliano M, Annicchiarico E, Agnes S, Giuliante F, Grieco A, Rapaccini GL, De Gaetano AM, Gasbarrini A, Bonomo L, HepatoCATT Study Group for the Multidisciplinary Management of HCC. Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma. Dig Liver Dis. 2015;47(3):242–8. https://doi.org/10.1016/j.dld.2014.12.007.CrossRefPubMed

22.

Zhang D, Liang W, Zhang M, Liang P, Gu Y, Kuang M, Cao F, Yu X, Liu F, Yu J. Multiple antenna placement in microwave ablation assisted by a three-dimensional fusion image navigation system for hepatocellular carcinoma. Int J Hyperthermia. 2019;35(1):122–32. https://doi.org/10.1080/02656736.2018.1484183.CrossRefPubMed

Titel: Balloon-Occluded MWA (b-MWA) Followed by Balloon-Occluded TACE (b-TACE): Technical Note on a New Combined Single-Step Therapy for Single Large HCC
verfasst von: Roberto Iezzi
Alessandro Posa
Alessandro Tanzilli
Francesca Carchesio
Maurizio Pompili
Riccardo Manfredi
Publikationsdatum: 16.07.2020
Verlag: Springer US
Erschienen in: CardioVascular and Interventional Radiology / Ausgabe 11/2020
Print ISSN: 0174-1551
Elektronische ISSN: 1432-086X
DOI: https://doi.org/10.1007/s00270-020-02583-6

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin